Innate Pharma raises €24.3 million in share placement

Innate Pharma SA, a pioneer in the field of cancer immunotherapies, has raised €24.3 million gross in a share placement supported by France’s Fonds Stratégique d’Investissement and existing investors, Novo Nordisk A/S and Alta Partners.

Location